INS and type 2 diabetes mellitus: The baseline characteristics of the T2D-MDI and T2D-B groups are shown in Table 1, together with the characteristics of 33,584 and 43,424 control participants (out of a total of 78,386) with T2D treated with multiple daily insulin injections or basal insulin, respectively, who used BGM testing only.